| abstract |
Disclosed is a phosphinate compound having HCV inhibitory activity. The present invention relates to antiviral phosphinate compounds, compositions comprising the compounds, and methods of treatment comprising administering the compounds, as well as methods and intermediates useful in the manufacture of the compounds. The compositions of the present invention are useful, for example, in the treatment of disorders associated with HCV. In one embodiment, the present invention also provides a pharmaceutical composition further comprising a nucleoside analog. The present invention also provides a pharmaceutical composition further comprising interferon or pegylated interferon. [Selection figure] None |